| PH12014500053A1 (en) | | Proteasome inhibitors |
| PH12015501191A1 (en) | | Boronate ester compounds and pharmaceutical compositions thereof |
| MY166653A (en) | | Derivatives of 1-amino-2-cyclobutylethylboronic acid |
| TN2012000465A1 (en) | | Derivatives of 1-amino-2-cyclopropylethylboronic acid |
| MX2009006706A (en) | | Bicyclic heterocyclic compounds as fgfr inhibitors. |
| MX2009006704A (en) | | New compounds. |
| IN2012DN00971A (en) | | |
| TW200602052A (en) | | Azaindoles useful as inhibitors of JAK and other protein kinases |
| SG161318A1 (en) | | Heterocyclic inhibitors of mek and methods of use thereof |
| MY163275A (en) | | Ibat inhibitors for the treatment of liver diseases |
| MA33803B1 (en) | | BENZODIAZEPINE BROMODOMAINE INHIBITOR |
| IL187382A0 (en) | | Bicyclic derivatives as modulators of ion channels |
| MX2009006327A (en) | | Heterocycle compounds and methods of use thereof. |
| TW200630090A (en) | | Triazoles useful as inhibitors of protein kinases |
| ZA201003352B (en) | | Heterocyclic derivatives as modulators of ion channels |
| EA201171414A1 (en) | | IAP FAMILY INHIBITORS |
| DE602007007934D1 (en) | | Imidazoazephinonverbindungen |
| MY180594A (en) | | Proteasome inhibitors |
| UA106205C2 (en) | | Boronate ester compounds, pharmaceutical compositions thereofand process for the preparation |
| EA201791835A3 (en) | | PROTEAS INHIBITORS |
| TW200716625A (en) | | Novel compounds |